US Stock MarketDetailed Quotes
ERNA Eterna Therapeutics
- 1.855
- +0.145+8.48%
Close May 3 16:00 ET
10.04MMarket Cap-454P/E (TTM)
2.000High1.720Low11.00KVolume1.720Open1.710Pre Close20.79KTurnover0.37%Turnover RatioLossP/E (Static)5.41MShares3.16052wk High4.49P/B5.48MFloat Cap0.84052wk Low--Dividend TTM2.95MShs Float1613.400Historical High--Div YieldTTM16.37%Amplitude0.840Historical Low1.890Avg Price1Lot Size
Eterna Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.71%-20.41M | 14.24%-4.66M | 4.74%-5.83M | 3.03%-3.87M | -11.36%-6.05M | 10.69%-20.98M | 20.45%-5.44M | 4.76%-6.12M | 41.31%-3.99M | -58.37%-5.43M |
| Net income from continuing operations | 11.84%-21.67M | -37.07%-6.15M | 23.59%-5.59M | -32.67%-4.51M | 42.23%-5.42M | 79.94%-24.58M | 43.55%-4.49M | 91.49%-7.32M | 66.31%-3.4M | 49.38%-9.38M |
| Operating gains losses | 98.07%-203K | 91.61%-38K | 97.69%-20K | 98.26%-190K | -97.34%45K | -212.45%-10.52M | ---453K | -191.58%-866K | -21,878.00%-10.89M | -82.36%1.69M |
| Depreciation and amortization | 125.96%1.12M | 459.30%481K | 327.27%517K | -58.55%63K | -55.07%62K | 8.28%497K | -30.08%86K | -2.42%121K | 29.91%152K | 45.26%138K |
| Other non cash items | 467.76%1.22M | 183.57%529K | 147.62%52K | 96.96%583K | -90.38%51K | -99.75%214K | ---633K | -99.97%21K | --296K | -90.81%530K |
| Change In working capital | -157.06%-2.12M | 203.50%355K | -166.11%-958K | -101.54%-34K | -470.93%-1.48M | 261.94%3.71M | 63.35%-343K | 157.27%1.45M | 12.50%2.21M | 150.83%399K |
| -Change in receivables | 301.15%527K | 5,508.00%1.35M | -241.38%-792K | -339.01%-337K | 308.22%304K | 60.24%-262K | 96.23%-25K | ---232K | 14,000.00%141K | -3,750.00%-146K |
| -Change in prepaid assets | -197.33%-556K | -330.93%-896K | -17.11%126K | 41.56%-599K | 172.82%813K | 78.00%-187K | 49.81%388K | -64.32%152K | 34.96%-1.03M | 626.83%298K |
| -Change in payables and accrued expense | -193.15%-4.65M | -2,157.47%-4.55M | -50.36%1.23M | -51.63%875K | -553.50%-2.2M | 1,128.87%4.99M | 176.47%221K | 220.21%2.47M | -31.16%1.81M | 163.45%486K |
| -Change in other current assets | 256.97%1.01M | 1,346.03%3.93M | -610.53%-2.43M | -578.18%-373K | -263.64%-108K | ---646K | -1,116.13%-315K | ---342K | ---55K | --66K |
| -Change in other current liabilities | 621.08%964K | 187.91%538K | 193.03%561K | -70.04%400K | -75.41%-535K | 37.71%-185K | -124.18%-612K | 30.45%-603K | 47.19%1.34M | -376.56%-305K |
| -Change in other working capital | --582K | ---17K | --349K | --0 | --250K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.71%-20.41M | 14.24%-4.66M | 4.74%-5.83M | 3.03%-3.87M | -11.36%-6.05M | 10.69%-20.98M | 20.45%-5.44M | 4.76%-6.12M | 41.31%-3.99M | -58.37%-5.43M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 59.57%-19K | -114.73%-19K | 0 | 0 | 0 | 99.79%-47K | 187.76%129K | 99.81%-43K | -8,600.00%-87K | -117.23%-46K |
| Net PPE purchase and sale | 59.57%-19K | -114.73%-19K | --0 | --0 | --0 | 69.48%-47K | 187.76%129K | -514.29%-43K | ---87K | ---46K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 59.57%-19K | -114.73%-19K | --0 | --0 | --0 | 99.79%-47K | 187.76%129K | 99.81%-43K | -8,600.00%-87K | -117.23%-46K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -15.44%16.56M | 1.46%7.7M | 142,233.33%8.54M | 2,500.00%312K | 0 | -68.21%19.58M | 1,912.17%7.59M | -99.83%6K | -100.03%-13K | 20.62%11.99M |
| Net issuance payments of debt | 825,250.00%16.5M | 778,900.00%7.79M | ---- | ---- | ---- | 99.79%-2K | 99.76%-1K | ---- | ---- | ---- |
| Net common stock issuance | -98.38%320K | --0 | --0 | --320K | --0 | -68.48%19.71M | 470.64%7.71M | --0 | --0 | 14.49%11.99M |
| Cash dividends paid | 0.00%-16K | 0.00%-8K | --0 | ---- | ---- | -100.00%-16K | 0.00%-8K | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --0 | ---- | ---- | ---- | -30.00%7K | --0 | ---- | ---- | ---- |
| Net other financing activities | -116.38%-251K | 31.53%-76K | ---- | ---- | ---- | ---116K | ---111K | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -15.44%16.56M | 1.46%7.7M | 142,233.33%8.54M | 2,500.00%312K | --0 | -68.21%19.58M | 1,912.17%7.59M | -99.83%6K | -100.03%-13K | 20.62%11.99M |
| Net cash flow | ||||||||||
| Beginning cash position | -8.50%15.54M | -34.77%8.65M | -69.43%5.93M | -59.61%9.49M | -8.50%15.54M | 942.02%16.99M | -45.64%13.25M | -61.31%19.41M | 179.43%23.5M | 942.02%16.99M |
| Current changes in cash | -168.07%-3.87M | 32.23%3.02M | 144.11%2.71M | 13.02%-3.56M | -192.85%-6.05M | -109.40%-1.44M | 130.91%2.29M | 76.13%-6.15M | -109.80%-4.09M | -3.91%6.52M |
| End cash Position | -24.91%11.67M | -24.91%11.67M | -34.77%8.65M | -69.43%5.93M | -59.61%9.49M | -8.50%15.54M | -8.50%15.54M | -45.64%13.25M | -61.31%19.41M | 179.43%23.5M |
| Free cash flow | 3.98%-20.43M | 14.22%-4.68M | 5.41%-5.83M | 7.37%-3.87M | -10.42%-6.05M | 10.02%-21.27M | 21.82%-5.46M | 4.20%-6.16M | 38.57%-4.18M | -59.71%-5.48M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg